Grants in Belgium

Closed

Funds Brussels-based research-industry consortia doing collaborative cleantech R&D, covering 40 to 60 percent of company costs and 100 percent of research organisation costs.

Closed

Funds Flemish research projects by universities in foundational science and engineering.

Closed

Funds Brussels SMEs filing national or PCT international patents for their R&D results, covering 50 percent of patent application and procedure costs.

Closed

Funds Brussels companies developing their first technologically innovative prototype or service, covering 50 to 70 percent of the budget for technical and economic validation.

Closed

Funds Brussels companies doing industrial research, experimental development, or process innovation through grants covering 15 to 70 percent of project costs.

Discontinued

Invests in Walloon industrial, healthcare, and technology companies with minority equity for scale and strategic development.

Discontinued

Offers Welvaartsfonds as a recovery support facility for Flemish companies needing mezzanine financing support during stress periods.

Open

Funds small and medium enterprises across Europe via Eurostars Call 11 for collaborative innovation with international partners.

Open

Funds international R&D and innovation projects led by an SME through each country's own national funding body.

Open

Funds coordination of European nuclear research platforms across energy, medicine, space, maritime uses and radiation protection.

Open

Funds PIANOFORTE’s 2026-27 continuation, an EU radiation-safety research partnership — only for its current members and any partner who joins them.

Open

Funds industrial production of stable isotopes needed for radionuclide therapies and a more resilient European medical supply chain.

Open

Funds a €9.4M lithium-ion battery recycling pilot line in India, matched to a separately funded Indian project on the same schedule.

Open

Funds four €7.1M projects that make battery electrode materials cleaner to produce — via greener refining or plant-based sourcing instead of mined graphite.

Open

Funds three €5.25M projects that plug embodied and operational carbon data into building certificates, passports and BIM tools.

Open

Funds a €7M platform giving adolescent and young adult cancer patients and survivors personalized digital tools for coping and psychological support.

Open

Funds a €15M project that turns microbiome signals into a test for spotting cancer risk years ahead of any symptoms.

Open

Funds five projects, €5-6M each, that develop and test care approaches built around what cancer patients over 65 actually need during and after treatment.

Open

Funds three €5M projects that build earlier, AI-assisted palliative care models for cancer patients and test them in real clinical and home-based settings.

Open

Funds a €5M programme that pairs EU and Associated Country research institutions with Ukrainian cancer centres for joint training and staff exchanges.

Open

Funds up to four €8-9M grants for teams building AI-driven digital models of a patient's cancer to predict how it develops and guide personalised treatment.

Open

Funds three pragmatic clinical trials, €7-8M each, testing existing cancer immunotherapies in real-world care for patients whose disease resists treatment.

Open

Funds eight €15–25M lump-sum projects that turn carbon capture, clean energy and circular production ideas into market-ready industrial demonstrations.

Open

Funds €15–25M lump-sum projects led by industry to mature energy, power, storage, fuels or CCU solutions from TRL 6 to market-ready deployment.